mvjrМедицинский вестник Юга РоссииMedical Herald of the South of Russia2219-80752618-7876The Rostov State Medical University10.21886/2219-8075-2014-1-35-38mvjr-213Research ArticleОБЗОРЫREVIEWНПВП-ГАСТРОПАТИЯ, АССОЦИИРОВАННАЯ С HELICOBACTERPYLORI: ГЕНЕЗ И ПРИНЦИПЫ ЛЕЧЕНИЯNSAI-GASTROPATHY ASSOCIATED WITH HELICOBACTER PYLORI: ORIGINATION AND BASIC THERAPYГолубкинаЕ. В.GolubkinaE. V.УмероваА. Р.UmerovaA. R.КамневаН. В.KamnevaN. V.kamnevy@mail.ruПановА. Н.PanovA. N.СорокинВ. М.SorokinV. M.Астраханская государственная медицинская академияRussian FederationГородская клиническая больница №3Russian FederationРостовский-на-Дону противочумный институтRussian Federation201430032014013538Copyright © Голубкина Е.В., Умерова А.Р., Камнева Н.В., Панов А.Н., Сорокин В.М., 20142014Голубкина Е.В., Умерова А.Р., Камнева Н.В., Панов А.Н., Сорокин В.М.Golubkina E.V., Umerova A.R., Kamneva N.V., Panov A.N., Sorokin V.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.medicalherald.ru/jour/article/view/213

Рассматриваются различные группы нестероидных противовоспалительных препаратов с точки зрения их эффективности и безопасности. Представлены сведения о возможных осложнениях со стороны желудочно-кишечного тракта. Приводятся принципы медикаментозного лечения НПВП-гастропатии, ассоциированной и неассоциированной с Helicobacter pylori.

Different groups of non-steroidal anti-inflammatory remedies are analyzed in respect of its efficacy and safety. The information concerning gastric and intestinal sequelae is presented. The approaches in treatment of NSAI-gastropathy are shown in dependence of Helicobacter pylori involvement into the affection.

гастропатиянестероидные противовоспалительные препаратыингибитора протоновой помпыHelicobacter pylorigastropathynon-steroidal anti-inflammatory drugsproton pump inhibitorHelicobacter pyloriReferencesЛазебник, Л.Б. Заболевания органов пищеварения у пожилых/Дроздов В.Н.//М.: Анахарсис. -2003. -180 с.Лазебник, Л.Б. Заболевания органов пищеварения у пожилых/Дроздов В.Н.//М.: Анахарсис. -2003. -180 с.Parfitt J., Driman D. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 2007. -Vol. 38. -P. 527-36.Parfitt J., Driman D. Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 2007. -Vol. 38. -P. 527-36.Лапина Т.Л. Лечение и профилактика гастропатий, индуцированных нестероидными противовоспалительными средствами, в практике терапевта/Т.Л. Лапина//Росс.журн. гастроэнтерол., гепатол., колопроктол. -2009. -№4. -С. 13-18.Лапина Т.Л. Лечение и профилактика гастропатий, индуцированных нестероидными противовоспалительными средствами, в практике терапевта/Т.Л. Лапина//Росс.журн. гастроэнтерол., гепатол., колопроктол. -2009. -№4. -С. 13-18.Насонов Е.Л. Применение нестероидных противовоспалительных препаратов: терапевтические перспективы/Е.Л. Насонов -Росс.мед. журн. -2002. -Т. 10, №4. -С. 206-212.Насонов Е.Л. Применение нестероидных противовоспалительных препаратов: терапевтические перспективы/Е.Л. Насонов -Росс.мед. журн. -2002. -Т. 10, №4. -С. 206-212.Каратеев, А.Е. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации/Яхно Н.Н., Лазебник Л.Б. и др./-М.: ИМА-ПРЕСС, 2009. -167 с.Каратеев, А.Е. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации/Яхно Н.Н., Лазебник Л.Б. и др./-М.: ИМА-ПРЕСС, 2009. -167 с.Свинцицкий А.С. Ингибиторы ЦОГ-2: панацея от побочных эффектов нестероидных противовоспалительных средств или новые проблемы?/А.С. Свинцицкий,Н.И. Хомченкова, О.Г. Пузанова//-Сучасна гастроентерологiя. -2003. -№1 (11). -С. 11-16.Свинцицкий А.С. Ингибиторы ЦОГ-2: панацея от побочных эффектов нестероидных противовоспалительных средств или новые проблемы?/А.С. Свинцицкий,Н.И. Хомченкова, О.Г. Пузанова//-Сучасна гастроентерологiя. -2003. -№1 (11). -С. 11-16.Lain L. Proton pump inhibitor co-therapy with nonsteroidal antiinflammatory drugs -nice or necessery?//RewGastroenterol Dis. -2004. -Vol. 4. -P. 33-41.Lain L. Proton pump inhibitor co-therapy with nonsteroidal antiinflammatory drugs -nice or necessery?//RewGastroenterol Dis. -2004. -Vol. 4. -P. 33-41.Lanas A. Prevention and treatment of NSAID-induced gastrointestinal injury//Curr Treat Options Gastroenterol. -2006. -Vol. 9. -P. 147-56.Lanas A. Prevention and treatment of NSAID-induced gastrointestinal injury//Curr Treat Options Gastroenterol. -2006. -Vol. 9. -P. 147-56.Швец Н.И. Осложнения со стороны пищеварительного тракта, обусловленные применением нестероидных противовоспалительных препаратов. Часть 2. Снижение риска развития и лечения гастропатий/Н.И. Швец, Т.М. Бенца//Укр. мед. часопис. -2004. -№5 (43). -С. 75-82.Швец Н.И. Осложнения со стороны пищеварительного тракта, обусловленные применением нестероидных противовоспалительных препаратов. Часть 2. Снижение риска развития и лечения гастропатий/Н.И. Швец, Т.М. Бенца//Укр. мед. часопис. -2004. -№5 (43). -С. 75-82.Henry D., Lim LL-Y., Garcia Rodriguez L.A., et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.//BMJ 1996. -Vol.312. -P. 1563-6.Henry D., Lim LL-Y., Garcia Rodriguez L.A., et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.//BMJ 1996. -Vol.312. -P. 1563-6.Lewis S.C., Langman M., Laporte J.-R. et al. Dose-response relationships between individual nonaspirinnonsteroidal anti-inflammatory drugs and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.//Br J ClinPharmacol. -2002. -Vol. 54. -№3. -P. 320-326.Lewis S.C., Langman M., Laporte J.-R. et al. Dose-response relationships between individual nonaspirinnonsteroidal anti-inflammatory drugs and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.//Br J ClinPharmacol. -2002. -Vol. 54. -№3. -P. 320-326.Chen Y.F., Jobanputra P., Barton P., et al/Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.//Health Technol Assess. -2008. -Vol. 12. -№11. -P. 1-278.Chen Y.F., Jobanputra P., Barton P., et al/Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.//Health Technol Assess. -2008. -Vol. 12. -№11. -P. 1-278.Rostom A., Muir K., Dube C. et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review.//ClinGastroenterolHepatol. 2007. -Vol. 5. -№7. -P. 818-28.Rostom A., Muir K., Dube C. et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review.//ClinGastroenterolHepatol. 2007. -Vol. 5. -№7. -P. 818-28.Laharie D., Droz-Perroteau C., Benichou J. et al. Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.//Br J ClinPharmacol. -2010. -Vol. 69. -№3. -P. 295-302.Laharie D., Droz-Perroteau C., Benichou J. et al. Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users.//Br J ClinPharmacol. -2010. -Vol. 69. -№3. -P. 295-302.Rainsford K.D. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide.//Inflammopharmacology. -2006. -Vol. 14. -№ 3-4. -P. 120-37.Rainsford K.D. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide.//Inflammopharmacology. -2006. -Vol. 14. -№ 3-4. -P. 120-37.Каратеев, А.Е. Эффективность и безопасность монотерапии высокими дозами НПВП при раннем артрите/Каратеев Д.Е., Лучихина Е.Л. и др.//РМЖ. -2006. -№16. -С. 24-29.Каратеев, А.Е. Эффективность и безопасность монотерапии высокими дозами НПВП при раннем артрите/Каратеев Д.Е., Лучихина Е.Л. и др.//РМЖ. -2006. -№16. -С. 24-29.Pilotto A., Franceschi M., Leandro G., et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs//Aging ClinExp Res. -2003. -Vol. 15. -№6. -P. 494-499.Pilotto A., Franceschi M., Leandro G., et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs//Aging ClinExp Res. -2003. -Vol. 15. -№6. -P. 494-499.Bradbury, F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice/Bradbury F.//Int J ClinPract (Suppl). -2004. -Vol. 144. -P. 27-32.Bradbury, F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice/Bradbury F.//Int J ClinPract (Suppl). -2004. -Vol. 144. -P. 27-32.Laporte J., Ibanez L., Vidal X., Vendrell L., Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents//Drug Saf. -2004. -Vol. 27. -P. 411-420.Laporte J., Ibanez L., Vidal X., Vendrell L., Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents//Drug Saf. -2004. -Vol. 27. -P. 411-420.Hawkey C.J., Lanas A.I. Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.//Am. J. Med. -2001. -V. 110. -P. 79S-100S.Hawkey C.J., Lanas A.I. Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement.//Am. J. Med. -2001. -V. 110. -P. 79S-100S.Lanza F.L., Chan F., Quigley E. et al. Guidelines for Prevention of NSAID-Related Ulcer Complications//Am J Gastroenterol. -2009. -Vol. 104. -P. 728 -738.Lanza F.L., Chan F., Quigley E. et al. Guidelines for Prevention of NSAID-Related Ulcer Complications//Am J Gastroenterol. -2009. -Vol. 104. -P. 728 -738.Rostom A., Dube C., Wells G.A. et al. Prevention of NSAID-induced gastroduodenal ulcers//Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD002296. DOI: DOI: 10.1002/14651858.CD002296Rostom A., Dube C., Wells G.A. et al. Prevention of NSAID-induced gastroduodenal ulcers//Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD002296. DOI: DOI: 10.1002/14651858.CD002296Hermansson M., Ekedahl A., Ranstam J., Zilling Th. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.//BMC Gastroenterol. -2009. -Vol. 9. -P. 25.Hermansson M., Ekedahl A., Ranstam J., Zilling Th. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.//BMC Gastroenterol. -2009. -Vol. 9. -P. 25.RegulaJa., ButrukEu., Dekkers C. et al. Prevention of NSAID-Associated Gastrointestinal Lesions: A Comparison Study Pantoprazole versus Omeprazole.//Amer. J. Gastroenterol. -2006. -Vol. 101. -P. 1747 -1755.RegulaJa., ButrukEu., Dekkers C. et al. Prevention of NSAID-Associated Gastrointestinal Lesions: A Comparison Study Pantoprazole versus Omeprazole.//Amer. J. Gastroenterol. -2006. -Vol. 101. -P. 1747 -1755.Malfertheiner P., Megraud F., O`Morain C. et al. Current concept in the management of Helicobacter pylori infection: the Maasticht III Consensus Report.//Gut. -2007. -Vol. 56. -P. 772-781.Malfertheiner P., Megraud F., O`Morain C. et al. Current concept in the management of Helicobacter pylori infection: the Maasticht III Consensus Report.//Gut. -2007. -Vol. 56. -P. 772-781.Chiba Т., Sato K., Endo M. et al. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs//Hepa-to gastroenterology. -2005. -Vol. 52. -№ 64. -P. 1134-1138.Chiba Т., Sato K., Endo M. et al. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs//Hepa-to gastroenterology. -2005. -Vol. 52. -№ 64. -P. 1134-1138.Bobrzynski, A. Helicobacter pylori and nonsteroidal antiinflammatory drugs in perforations and bleeding of peptic ulcers/Konturek P. C, Konturek S. J. et al.//Med. Sci. Monit. -2005. -Vol. 11. -№ 3. -P. 132-135.Bobrzynski, A. Helicobacter pylori and nonsteroidal antiinflammatory drugs in perforations and bleeding of peptic ulcers/Konturek P. C, Konturek S. J. et al.//Med. Sci. Monit. -2005. -Vol. 11. -№ 3. -P. 132-135.Matsukawa Y., Aoki M., Nishinarita S. et al. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer//Rheumatology (Oxford) -2003. -Vol. 42. -№8. -P. 947-950.Matsukawa Y., Aoki M., Nishinarita S. et al. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer//Rheumatology (Oxford) -2003. -Vol. 42. -№8. -P. 947-950.Vergara M., Catalan M., Gisbert J. P. et al. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users//Aliment. Pharmacol. Ther. -2005. -Vol. 21. -№ 12. -P. 1411-1418.Vergara M., Catalan M., Gisbert J. P. et al. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users//Aliment. Pharmacol. Ther. -2005. -Vol. 21. -№ 12. -P. 1411-1418.Chan, F. K. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or lowdose aspirin?/Chan F. K.//Chin. J. Dig. Dis. 2005. -Vol. 6. -№ 1. -P. 1-5.Chan, F. K. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or lowdose aspirin?/Chan F. K.//Chin. J. Dig. Dis. 2005. -Vol. 6. -№ 1. -P. 1-5.Wu C. Y, Wu M. S., Chen C. J. et al. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.//Clin. Gastroenterol. -2005. -Vol. 39. -№1. -P. 50-55.Wu C. Y, Wu M. S., Chen C. J. et al. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.//Clin. Gastroenterol. -2005. -Vol. 39. -№1. -P. 50-55.Giral A., Ozdogan O., Celikel C. A. et al. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.//J. Gastroenterol. Hepatol. -2004. -Vol. 19. -№ 7. -P. 773-777.Giral A., Ozdogan O., Celikel C. A. et al. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.//J. Gastroenterol. Hepatol. -2004. -Vol. 19. -№ 7. -P. 773-777.Lazzaroni M., Bianchi Porro G., Ph D. Nonsteroidal antiinflammatory drug gastropathy and Helicobacter pylori: the search for an improbable consensus//2001. -Vol.101. -P. 50-51.Lazzaroni M., Bianchi Porro G., Ph D. Nonsteroidal antiinflammatory drug gastropathy and Helicobacter pylori: the search for an improbable consensus//2001. -Vol.101. -P. 50-51.Iijima K., Ara N., Abe Y. et al. Biphasic effects of H.pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.//Journal of Gastroenterology -2012. -Vol. 47. -№12. -P. 1290-1297.Iijima K., Ara N., Abe Y. et al. Biphasic effects of H.pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.//Journal of Gastroenterology -2012. -Vol. 47. -№12. -P. 1290-1297.Lai К. C, Lau C. S., Ip W. Y. et al. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.//Aliment. Pharmacol. Ther. -2003. -Vol. 17. -№6. -P. 799-805.Lai К. C, Lau C. S., Ip W. Y. et al. Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.//Aliment. Pharmacol. Ther. -2003. -Vol. 17. -№6. -P. 799-805.Ji K. Y., Ни F. J., Li A. D. et al. Interaction of Helicobacter pylori and indomethacin in gastric mucosa injury of Balb/c mice.//Zhonghua Yi XueZaZhi -2003. -Vol. 83. -№9. -P. 726-730.Ji K. Y., Ни F. J., Li A. D. et al. Interaction of Helicobacter pylori and indomethacin in gastric mucosa injury of Balb/c mice.//Zhonghua Yi XueZaZhi -2003. -Vol. 83. -№9. -P. 726-730.Tzourmakliotis D., Economou M., Manolakopoulos S. et al. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study//Scand. J. Gasroenterol. -2004. -Vol. 39. -№ 12. -P. 1180-1185.Tzourmakliotis D., Economou M., Manolakopoulos S. et al. Clinical significance of cytotoxin-associated gene A status of Helicobacter pylori among non-steroidal anti-inflammatory drug users with peptic ulcer bleeding: a multicenter case-control study//Scand. J. Gasroenterol. -2004. -Vol. 39. -№ 12. -P. 1180-1185.Стандарты диагностики и лечения кислотозависимых и ассоциированных с Helicobacterpylori заболеваний. Методические рекомендации./Лазебник Л.Б., Щербаков П.Л., Васильев Ю.В. и др.//ЦНИИ гастроэнтерологии. -Москва, 2010. -12 с.Стандарты диагностики и лечения кислотозависимых и ассоциированных с Helicobacterpylori заболеваний. Методические рекомендации./Лазебник Л.Б., Щербаков П.Л., Васильев Ю.В. и др.//ЦНИИ гастроэнтерологии. -Москва, 2010. -12 с.

The authors declare that there are no conflicts of interest present.